Team:TU Delft/30 July 2010 content
From 2010.igem.org
(Difference between revisions)
Line 1: | Line 1: | ||
- | =Alkane Sensing, Solvent Tolerance and Salt Tolerance= | + | =Lab work= |
+ | |||
+ | ==Alkane Degradation== | ||
+ | |||
+ | ====PCR Amplification==== | ||
+ | [https://2010.igem.org/Team:TU_Delft#page=pages/blog&blog=29_July_2010 Yesterday's] were ligation mixes were [[Team:TU_Delft/protocols/PCR|amplified]] with the primers PCR F and PCR R. The product was put on [[Team:TU_Delft/protocols/agarose_gel|1% agarose gel]]: | ||
+ | |||
+ | Lane Description: | ||
+ | {|style="color:black; background-color:white;" cellpadding="5" cellspacing="0" border="1" | ||
+ | |'''#''' | ||
+ | |'''Description''' | ||
+ | |'''Expected Length (bp)''' | ||
+ | |'''Primers''' | ||
+ | |'''Status''' | ||
+ | |'''Remarks''' | ||
+ | |- | ||
+ | |1 | ||
+ | |PCR product of 007 + 008 | ||
+ | | | ||
+ | |PCR F + PCR R | ||
+ | |<font color=limegreen>✓</font> | ||
+ | | | ||
+ | |- | ||
+ | |2 | ||
+ | |PCR product of 009 + 010 | ||
+ | | | ||
+ | |PCR F + PCR R | ||
+ | |<font color=limegreen>✓</font> | ||
+ | | | ||
+ | |- | ||
+ | |3 | ||
+ | |PCR product of 017 + 018 | ||
+ | | | ||
+ | |PCR F + PCR R | ||
+ | |<font color=red>✗</font> | ||
+ | | | ||
+ | |- | ||
+ | |4 | ||
+ | |PCR product of 019 + B0015 | ||
+ | | | ||
+ | |PCR F + PCR R | ||
+ | |<font color=limegreen>✓</font> | ||
+ | | | ||
+ | |- | ||
+ | |5 | ||
+ | |PCR product of 007 (negative control) | ||
+ | | | ||
+ | |PCR F + PCR R | ||
+ | |<font color=red>✗</font> | ||
+ | |The primers also anneal without a complete ligation | ||
+ | |- | ||
+ | |M1 | ||
+ | |SmartLadder | ||
+ | |n/a | ||
+ | |n/a | ||
+ | |n/a | ||
+ | |} | ||
+ | |||
+ | ====Digestion==== | ||
+ | The PCR products were subsequently [[Team:TU_Delft/protocols/restriction_enzyme_digestion|digested]]: | ||
+ | |||
+ | {| style="color:black; background-color:white;" cellpadding="5" cellspacing="0" border="1" | ||
+ | |'''#''' | ||
+ | |'''Sample''' | ||
+ | |'''Enzyme 1''' | ||
+ | |'''Enzyme 2''' | ||
+ | |'''Buffer''' | ||
+ | |'''BSA''' | ||
+ | |'''Needed fragment''' | ||
+ | |- | ||
+ | |1 | ||
+ | |40 μL PCR product 007 + 008 | ||
+ | |EcoRI | ||
+ | |PstI | ||
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘E–007 + 008–P’ | ||
+ | |- | ||
+ | |2 | ||
+ | |40 μL PCR product 009 + 010 | ||
+ | |EcoRI | ||
+ | |PstI | ||
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘E–009 + 010-P’ | ||
+ | |- | ||
+ | |3 | ||
+ | |40 μL PCR product 017 + 018 | ||
+ | |EcoRI | ||
+ | |PstI | ||
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘E–017 + 018–P’ | ||
+ | |- | ||
+ | |4 | ||
+ | |40 μL PCR product 019 + B0015 | ||
+ | |EcoRI | ||
+ | |PstI | ||
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘E–019 + B0015-P’ | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | ==Alkane Sensing, Solvent Tolerance and Salt Tolerance== | ||
''by Pieter'' | ''by Pieter'' | ||
Line 10: | Line 114: | ||
To achieve this J06702, bbc1, PhPFDalpha and PhPFDbeta were amplified by PCR. The J61101 was cut open with S and P after which the biobricks were inserted. AlkS was inserted in the backbone with E0240. | To achieve this J06702, bbc1, PhPFDalpha and PhPFDbeta were amplified by PCR. The J61101 was cut open with S and P after which the biobricks were inserted. AlkS was inserted in the backbone with E0240. | ||
- | ==PCR== | + | ====PCR==== |
The [[Team:TU_Delft/protocols/PCR|PCR]] protocol was followed for the amplification of the BioBricks. | The [[Team:TU_Delft/protocols/PCR|PCR]] protocol was followed for the amplification of the BioBricks. | ||
Line 21: | Line 125: | ||
|'''Primer''' | |'''Primer''' | ||
|'''Status''' | |'''Status''' | ||
- | |||
|- | |- | ||
|1 | |1 | ||
Line 28: | Line 131: | ||
|n/a | |n/a | ||
|n/a | |n/a | ||
- | |||
|- | |- | ||
|2 | |2 | ||
Line 35: | Line 137: | ||
|G00100 + G00101 | |G00100 + G00101 | ||
|<font color=red>✗</font> | |<font color=red>✗</font> | ||
- | |||
|- | |- | ||
|3 | |3 | ||
Line 42: | Line 143: | ||
|MF + MR2 | |MF + MR2 | ||
|<font color=limegreen>✓</font> | |<font color=limegreen>✓</font> | ||
- | |||
|- | |- | ||
|4 | |4 | ||
Line 49: | Line 149: | ||
|MF + MR2 | |MF + MR2 | ||
|<font color=limegreen>✓</font> | |<font color=limegreen>✓</font> | ||
- | |||
|- | |- | ||
|5 | |5 | ||
Line 56: | Line 155: | ||
|MF + MR2 | |MF + MR2 | ||
|<font color=limegreen>✓</font> | |<font color=limegreen>✓</font> | ||
- | |||
|} | |} | ||
- | ==Digestion== | + | ====Digestion==== |
The PCR products were subsequently [[Team:TU_Delft/protocols/restriction_enzyme_digestion|digested]]: | The PCR products were subsequently [[Team:TU_Delft/protocols/restriction_enzyme_digestion|digested]]: | ||
Line 137: | Line 235: | ||
|} | |} | ||
- | ==Ligation== | + | ====Ligation==== |
The digestion products were [[Team:TU_Delft/protocols/ligation|ligated]] over two nights: | The digestion products were [[Team:TU_Delft/protocols/ligation|ligated]] over two nights: | ||
Revision as of 20:51, 5 August 2010
Contents |
Lab work
Alkane Degradation
PCR Amplification
Yesterday's were ligation mixes were amplified with the primers PCR F and PCR R. The product was put on 1% agarose gel:
Lane Description:
# | Description | Expected Length (bp) | Primers | Status | Remarks |
1 | PCR product of 007 + 008 | PCR F + PCR R | ✓ | ||
2 | PCR product of 009 + 010 | PCR F + PCR R | ✓ | ||
3 | PCR product of 017 + 018 | PCR F + PCR R | ✗ | ||
4 | PCR product of 019 + B0015 | PCR F + PCR R | ✓ | ||
5 | PCR product of 007 (negative control) | PCR F + PCR R | ✗ | The primers also anneal without a complete ligation | |
M1 | SmartLadder | n/a | n/a | n/a |
Digestion
The PCR products were subsequently digested:
# | Sample | Enzyme 1 | Enzyme 2 | Buffer | BSA | Needed fragment |
1 | 40 μL PCR product 007 + 008 | EcoRI | PstI | 2 (BioLabs) | ✓ | ‘E–007 + 008–P’ |
2 | 40 μL PCR product 009 + 010 | EcoRI | PstI | 2 (BioLabs) | ✓ | ‘E–009 + 010-P’ |
3 | 40 μL PCR product 017 + 018 | EcoRI | PstI | 2 (BioLabs) | ✓ | ‘E–017 + 018–P’ |
4 | 40 μL PCR product 019 + B0015 | EcoRI | PstI | 2 (BioLabs) | ✓ | ‘E–019 + B0015-P’ |
Alkane Sensing, Solvent Tolerance and Salt Tolerance
by Pieter
I tried to assemble the remaining biobricks from various sub projects. The goal is to assemble the following:
- AlkS + E0240
- PalkB + J06702
- J61101 + bbc1
- J61101 + PhPFDalpha
- J61101 + PhPFDbeta
To achieve this J06702, bbc1, PhPFDalpha and PhPFDbeta were amplified by PCR. The J61101 was cut open with S and P after which the biobricks were inserted. AlkS was inserted in the backbone with E0240.
PCR
The PCR protocol was followed for the amplification of the BioBricks.
PCR reactions
# | Description | Expected lenght (bp) | Primer | Status |
1 | Marker | n/a | n/a | n/a |
2 | J06702 | 869 | G00100 + G00101 | ✗ |
3 | bbc1 | 703 | MF + MR2 | ✓ |
4 | PhPFDalpha | 528 | MF + MR2 | ✓ |
5 | PhPFDbeta | 430 | MF + MR2 | ✓ |
Digestion
The PCR products were subsequently digested:
# | Sample | Enzyme 1 | Enzyme 2 | Buffer | BSA | Needed fragment |
1 | 2 μL AlkS | EcoRI | SpeI | 2 (BioLabs) | ✓ | ‘E–AlkS–S’ |
2 | 3 μL E0240 | EcoRI | XbaI | 2 (BioLabs) | ✓ | ‘X–E0240–E’ |
3 | 16 μL PalkB | SpeI | PstI | 2 (BioLabs) | ✓ | ‘P–PalkB–S’ |
4 | 40 μL J06702 PCR product | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–J06702–P’ |
5 | 6 μL J61101 | SpeI | PstI | 2 (BioLabs) | ✓ | ‘P–J61101–S’ |
6 | 40 μL bbc1 PCR product | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–J61101–P’ |
7 | 40 μL PhPFDalpha PCR product | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–PhPFDalpha–P’ |
8 | 40 μL PhPFDbeta PCR product | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–PhPFDalpha–P’ |
Ligation
The digestion products were ligated over two nights:
# | BioBrick | Fragment 1 | Fragment 2 | Final volume |
1 | AlkS + E0240 | 10 μL ‘E–AlkS–S’ | 10 μL ‘X–E0240–E’ | 25 μL |
2 | J61101 + bbc1 | 7 μL ‘P–J61101–S’ | 1 μL ‘X–J61101–P’ | 10 μL |
3 | J61101 + PhPFDalpha | 7 μL ‘P–J61101–S’ | 1 μL ‘X–PhPFDalpha–P’ | 10 μL |
4 | J61101 + PhPFDbeta | 7 μL ‘P–J61101–S’ | 1 μL ‘X–PhPFDbeta–P’ | 10 μL |